India Equity: Gland_Pharma (#GLAND) declares Quarterly Results. EPS = Rs 21.39 for quarter ended Jun 2021

0
405

GLAND has declared results for the period ended Jun 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

  • Sales for period ended Jun 2021 is Rs 1154.0 cr compared to Rs 884.0 cr for period ended Jun 2020, a rise of 30.5%
  • Operating Profits reported at Rs 436.0 cr for period ended Jun 2021 vis-vis 413.0 for period ended Jun 2020 .
  • Operating Margins contracted -893.8 bps for period ended Jun 2021 vis-vis Jun 2020 .
  • The EPS for Jun 2021 was Rs 21.39 compared to Rs 15.92 for previous quarter ended Mar 2021 and Rs 0 for Jun 2020
  • The stock is trading at Rs 3795 and a market cap of Rs 62326 cr

[/s2If]

Trading Chart


Further analysis and Full Company Research with investing scores is available here: GLAND

Join Our Telegram Group
Join Our Twitter

This site uses Akismet to reduce spam. Learn how your comment data is processed.